Insulet (PODD) Tops Q3 EPS by 4c; Boosts FY16 Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
Tweet
Share
E-mailGet Alerts PODD Hot Sheet
Price: $148.93 --0%
Revenue Growth %: +17.9%
Financial Fact:
Revenue: 94.87M
Today's EPS Names:
CCB, ESCA, MPT, More
Revenue Growth %: +17.9%
Financial Fact:
Revenue: 94.87M
Today's EPS Names:
CCB, ESCA, MPT, More
Join SI Premium – FREE
Insulet (NASDAQ: PODD) reported Q3 EPS of ($0.05), $0.04 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $94.9 million versus the consensus estimate of $89.75 million.
GUIDANCE:
Insulet sees FY2016 revenue of $362-365 million, versus prior guidance of $345-355 million and the consensus of $351.5 million.
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Takeda Pharmaceutical Company Limited (TAK) Reports Q3 EPS of JPY308.00; offers guidance
- ING Groep N.V. (ING) Misses Q3 EPS by 2c; offers outlook
- TotalEnergies SE (TTE) Tops Q3 EPS by 43c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
